首页 | 本学科首页   官方微博 | 高级检索  
     

新型铂族金属抗肿瘤药物赛特铂的研究现状
引用本文:普绍平,高文桂,余尧,刘祝东,刘伟平,杨一昆.新型铂族金属抗肿瘤药物赛特铂的研究现状[J].贵金属,2002,23(4):53-57.
作者姓名:普绍平  高文桂  余尧  刘祝东  刘伟平  杨一昆
作者单位:昆明贵金属研究所,云南,昆明,650221
基金项目:国家“九五”攻关资助项目(85-772-26-01)
摘    要:铂族金属抗肿瘤药物顺铂和卡铂已广泛应用于临床,它们对治疗睾丸肿瘤、卵巢癌和肺癌等十几种肿瘤有显著的疗效。近年来又有奈达铂、 到铂和乐铂等获批准进入临床应用。但目前这些临床应用的铂族金属抗肿瘤药口服活性低,都是静脉途径给药。本文介绍了已进入Ⅲ期临床试验的第一个口服活性铂抗肿瘤药物赛特铂及其合成、化学特点、临床前和临床研究情况。

关 键 词:铂族金属  抗肿瘤药物  赛特铂  研究现状
文章编号:1004-0676(2002)04-0053-05
修稿时间:2002年2月20日

Current Status of Satraplatin-An Oral Active Platinum Drug
Pu Shaoping,Gao Wengui,Yu Yao,Liu Zhudong,Liu Weiping,Yang Yikun.Current Status of Satraplatin-An Oral Active Platinum Drug[J].Precious Metals,2002,23(4):53-57.
Authors:Pu Shaoping  Gao Wengui  Yu Yao  Liu Zhudong  Liu Weiping  Yang Yikun
Abstract:Cisplatin and carboplatin of the platinum - based drugs, have been widely used in the clinical practice, and with the significant effectiveness to treat testicular cancer, ovarian carcinomas, lung cancer and bladder cancer etc. Recently, some other platinum - based drugs, such as nedaplatin, lobaplatin and oxaliplatin, have also been approved to enter the clinical applications. But these platinum - based drugs used in the clinical at present have poor absorption by the oral route. In this paper, the first oral active platinum - based drug, satraplatin, including it s synthesis, the chemical properties, the preclinical and clinical studies, were introduced.
Keywords:Oral active platinum drug  Satraplatin  Current status
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号